Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uveal Melanoma × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 200 Breast Neoplasms 116 Neoplasms 82 Prostatic Neoplasms 32 Fatigue 28 Obesity 22 Colorectal Neoplasms 19 Lung Neoplasms 16 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Colonic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma 10 Lymphedema 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Hematologic Neoplasms 8 Cardiotoxicity 8 Brain Neoplasms 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Overweight 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Lymphoma, Follicular 5

Interventions

Ipilimumab 25 Nivolumab 19 pembrolizumab 11 incomplete Freund's adjuvant 10 Cyclophosphamide 9 Melphalan 8 Interleukin-2 8 sargramostim 7 MART-1 Antigen 7 CTLA-4 Antigen 7 Temozolomide 6 Ranibizumab 6 tebentafusp 5 montanide ISA 51 5 Sunitinib 5 Radiosurgery 5 Dacarbazine 5 aldesleukin 4 aflibercept 4 Magnetic Resonance Spectroscopy 4 Carboplatin 4 Blood Specimen Collection 4 Biopsy 4 Bevacizumab 4 trametinib 3 sotrastaurin 3 fludarabine phosphate 3 fludarabine 3 binimetinib 3 Vorinostat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06970236 2025-05-28

IHOPE

University of Valencia

Phase NA Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡